These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6300667)

  • 41. Metabolic activation of 3-methylcholanthrene and benzo(a)pyrene to mutagens in the L5178Y/TK assay by cultured embryonic rodent cells.
    Amacher DE; Paillet SC; Zelljadt I
    Environ Mutagen; 1982; 4(2):109-19. PubMed ID: 7075576
    [No Abstract]   [Full Text] [Related]  

  • 42. Formation and removal of benzo[a]pyrene metabolites--DNA adducts in cultured normal human fibroblasts using a microsome-activating system.
    Kaneko M
    Mutat Res; 1984; 131(3-4):157-61. PubMed ID: 6325902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the metabolism of benzo[a]pyrene and its activation to biologically active metabolites by low-passage hamster and rat embryo cells.
    Baird WM; O'Brien TG; Diamond L
    Carcinogenesis; 1981; 2(2):81-8. PubMed ID: 6268323
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of a 6-fluoro substituent on the metabolism and biological activity of benzo(a)pyrene.
    Buhler DR; Unlü F; Thakker DR; Slaga TJ; Conney AH; Wood AW; Chang RL; Levin W; Jerina DM
    Cancer Res; 1983 Apr; 43(4):1541-9. PubMed ID: 6299523
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of norharman on the metabolism of benzo[alpha]pyrene by rat-liver microsomes in vitro in relation to its enhancement of the mutagenicity of benzo[alpha]pyrene.
    Fujino T; Fujiki H; Nagao M; Yahagi T; Seino Y; Sugimura T
    Mutat Res; 1978 Nov; 58(2-3):151-8. PubMed ID: 370567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An intestinal cell-mediated chromosome aberration test for the detection of genotoxic agents.
    Whitehead FW; San RH; Stich HF
    Mutat Res; 1983 Oct; 111(2):209-17. PubMed ID: 6314130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of epoxide and free-radical mechanisms for activation of benzo[a]pyrene by Sprague-Dawley rat liver microsomes.
    Selkirk JK
    J Natl Cancer Inst; 1980 Apr; 64(4):771-4. PubMed ID: 6928990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of avian and rodent S-9 liver homogenates in the Ames test.
    Rosanoff KA; Jones DH; Sawyer TW
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):131-9. PubMed ID: 6328598
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aryl hydrocarbon (benzo(a)pyrene) hydroxylase in microsomes from rat tissues: differential inhibition and stimulation by benzoflavones and organic solvents.
    Wiebel FJ; Leutz JC; Diamond L; Gelboin HV
    Arch Biochem Biophys; 1971 May; 144(1):78-86. PubMed ID: 5117540
    [No Abstract]   [Full Text] [Related]  

  • 50. Effect of benzo(a)pyrene induction of liver and lung metabolism in adjuvant-diseased rats.
    Carlson RP; Ciaccio EI
    Biochem Pharmacol; 1975 Oct; 24(20):1893-5. PubMed ID: 1191340
    [No Abstract]   [Full Text] [Related]  

  • 51. The microsomal metabolism of benzo(a) pyrene phenols.
    Capdevila J; Estabrook RW; Prough RA
    Biochem Biophys Res Commun; 1978 May; 82(2):518-25. PubMed ID: 27193
    [No Abstract]   [Full Text] [Related]  

  • 52. Divergence of metabolic activation systems for short-term mutagenesis assays.
    Selkirk JK
    Nature; 1977 Dec; 270(5638):604-7. PubMed ID: 593384
    [No Abstract]   [Full Text] [Related]  

  • 53. The kinetics of benzo(a)pyrene anti-7,8-dihydrodiol 9, 10-epoxide formation from benzo(a)pyrene and regulatory membrane effects.
    Fahl WE
    Arch Biochem Biophys; 1982 Jul; 216(2):581-92. PubMed ID: 6287939
    [No Abstract]   [Full Text] [Related]  

  • 54. Metabolic conversion of benzo(a)pyrene by Syrian hamster liver microsomes and binding of metabolites to deoxyribonucleic acid.
    Borgen A; Darvey H; Castagnoli N; Crocker TT; Rasmussen RE; Wang IY
    J Med Chem; 1973 May; 16(5):502-6. PubMed ID: 4718466
    [No Abstract]   [Full Text] [Related]  

  • 55. Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate.
    Glatt HR; Billings R; Platt KL; Oesch F
    Cancer Res; 1981 Jan; 41(1):270-7. PubMed ID: 7448766
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of antioxidants on the metabolism and mutagenicity of benzo[a]pyrene in vitro.
    Rahimtula AD; Zachariah PK; O'Brien PJ
    Biochem J; 1977 May; 164(2):473-5. PubMed ID: 328015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Human breast cell-mediated mutagenesis of mammalian cells by polycyclic aromatic hydrocarbons.
    Gould MN; Cathers LE; Moore CJ
    Cancer Res; 1982 Nov; 42(11):4619-24. PubMed ID: 6290042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative benzo[a]pyrene metabolite patterns in fish and rodents.
    Melius P
    Natl Cancer Inst Monogr; 1984 May; 65():387-90. PubMed ID: 6087145
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microspectrofluorometric study of benzo(a)pyrene metabolization in benzo(a)pyrene-grown single living cells.
    Salmon JM; Kohen E; Kohen C; Bengtsson G
    Histochemistry; 1974; 42(1):85-98. PubMed ID: 4154930
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.